Crown ElectroKinetics Corp.(NASDAQ:CRKN) Q1 2022 Earnings Conference Call May 13, 2022 11:00 AM ET Company Participants Doug Croxall - CEO and Chairman Joel Krutz - CFO Conference Call Participants Jeffrey Campbell - Alliance Global Partners Shawn Severson - Water Tower Research Jim McIlree - Dawson James Operator Good day, everyone, and welcome to Crown ElectroKinetics Corp. Earnings Call for the First Quarter 2022. [Operator Instructions] This conference call is being recorded. A replay of today's call wi ...

Crown ElectroKinetics Corp. (NASDAQ:CRKN) Q3 2021 Earnings Conference Call March 30, 2022 11:00 AM ET Company Participants Doug Croxall - Chairman and Chief Executive Officer Joel Krutz - Chief Financial Officer Conference Call Participants Jeffrey Campbell - Alliance Global Partners Gerry Sweeney - ROTH Capital James McIlree - Dawson James Securities Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 333-232426 Crown Electrokinetics Corp. (Exact name of registrant as specified in its charter) | --- | --- | |------------- ...

DYNAMICTINT – WE MAKE YOUR GLASS SMARTERTM Crown Electrokinetics Corp. (NASDAQ: CRKN) October 2021 NASDAQ: CRKN May 2021 Safe Harbor Statement This presentation and other written or oral statements made from time to time by representatives of Crown Electrokinetics may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements reflect the current view about future events. ...

Crown ElectroKinetics Corp. (NASDAQ:CRKN) Q1 2022 Earnings Conference Call August 16, 2021 11:00 AM ET Company Participants Allison Soss – Investor Relations Doug Croxall – Chairman and Chief Executive Officer Joel Krutz – Chief Financial Officer Eddie Kovalik – President and Chief Operating Officer Conference Call Participants Gerry Sweeney – ROTH Capital Jim McIlree – Dawson James Securities Mike Shlisky – D.A. Davidson Jeffrey Campbell – Alliance Global Partners Operator Greetings and welcome to Crown El ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 333-232426 Crown Electrokinetics Corp. (Exact name of registrant as specified in its charter) | --- | --- | |------------------ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 333-249833 Crown Electrokinetics Corp. (Exact name of registrant as specified in its charter) | --- | --- | |------------------- ...

DYNAMICTINT – WE MAKE YOUR GLASS SMARTERTM Crown Electrokinetics Corp. (NASDAQ: CRKN) June 2021 NASDAQ: CRKN May 2021 Safe Harbor Statement This presentation and other written or oral statements made from time to time by representatives of Crown Electrokinetics may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements reflect the current view about future events. Sta ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 333-232426 Crown Electrokinetics Corp. (Exact name of registrant as specified in its charter) | --- | --- | |------------- ...

[PART I - FINANCIAL INFORMATION](index=4&type=section&id=PART%20I%20-%20FINANCIAL%20INFORMATION) This section presents the company's unaudited financial information for the reporting period, including statements and related notes [Financial Statements (Unaudited)](index=4&type=section&id=Item%201.%20Financial%20Statements%20(Unaudited)) This section presents the unaudited condensed financial statements for the quarter ended June 30, 2020, detailing the company's financial position, performance, and cash flows Condensed Balance Sheet Highlights (Unaudited) | Account | June 30, 2020 ($) | March 31, 2020 ($) | | :--- | :--- | :--- | | **Total Assets** | **912,091** | **388,636** | | Cash & cash equivalents | 591,851 | 48,307 | | **Total Liabilities** | **6,555,583** | **7,349,133** | | Notes payable, net | 2,215,403 | 3,083,158 | | Warrant liability | 2,314,152 | 1,733,718 | | **Total stockholders' deficit** | **(5,643,492)** | **(6,960,497)** | Condensed Statements of Operations (Unaudited) | Metric | Three Months Ended June 30, 2020 ($) | Three Months Ended June 30, 2019 ($) | | :--- | :--- | :--- | | Revenue | 0 | 0 | | Cost of revenue | 0 | 153,500 | | **Loss from operations** | **(9,310,079)** | **(1,849,779)** | | Research and development | 1,372,522 | 320,371 | | Selling, general and administrative | 7,937,557 | 1,375,908 | | **Net loss** | **(10,462,030)** | **(2,225,250)** | | **Net loss per share, basic and diluted** | **(0.61)** | **(0.20)** | [Condensed Statements of Stockholders' Deficit](index=6&type=section&id=Condensed%20Statements%20of%20Stockholders'%20Deficit) - The total stockholders' deficit decreased from **($6,960,497)** at March 31, 2020, to **($5,643,492)** at June 30, 2020, primarily driven by **$8.1 million** in stock-based compensation and stock issuances offsetting a **$10.5 million** net loss for the quarter[18](index=18&type=chunk) Condensed Statements of Cash Flows (Unaudited) | Activity | Three Months Ended June 30, 2020 ($) | Three Months Ended June 30, 2019 ($) | | :--- | :--- | :--- | | Net cash used in operating activities | (1,286,656) | (692,397) | | Net cash used in investing activities | 0 | (26,603) | | Net cash provided by financing activities | 1,830,200 | 620,000 | | **Net increase (decrease) in cash** | **543,544** | **(99,000)** | | **Cash — end of period** | **591,851** | **447** | [Notes to the Condensed Financial Statements (Unaudited)](index=8&type=section&id=Notes%20to%20the%20Condensed%20Financial%20Statements%20(Unaudited)) - The company has incurred substantial operating losses, with an accumulated deficit of approximately **$26.9 million** as of June 30, 2020, raising substantial doubt about its ability to continue as a going concern without additional financing[26](index=26&type=chunk)[27](index=27&type=chunk)[28](index=28&type=chunk) - On April 24, 2020, the company received a PPP Loan of **$197,200** under the CARES Act, with a fixed interest rate of **1%** and potential for forgiveness if used for qualifying expenses[63](index=63&type=chunk)[64](index=64&type=chunk)[65](index=65&type=chunk) - During the three months ended June 30, 2020, the company issued convertible notes with a principal balance of **$2,081,000** for proceeds of approximately **$2,050,000**, resulting in an outstanding principal balance of approximately **$3.4 million** as of the report date[88](index=88&type=chunk) - Total stock-based compensation expense for the three months ended June 30, 2020, was approximately **$8.1 million**, a significant increase from **$1.1 million** in the same period of 2019[137](index=137&type=chunk) - Subsequent to the quarter end, on September 11, 2020, the company sold **1,390,000 shares** and **695,000 warrants** in a private placement for gross proceeds of approximately **$1.7 million**[160](index=160&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=30&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses the company's electrokinetic glass technology business, highlighting a significant increase in net loss to **$10.5 million** due to higher operating expenses and expressing substantial doubt about its going concern ability - The company is commercializing electrokinetic glass technology, an advancement on microfluidic technology originally developed by Hewlett-Packard Company[165](index=165&type=chunk) Results of Operations Comparison (Unaudited) | Metric | Three Months Ended June 30, 2020 ($) | Three Months Ended June 30, 2019 ($) | | :--- | :--- | :--- | | Research and development | (1,372,522) | (320,371) | | Selling, general and administrative | (7,937,557) | (1,375,908) | | **Net Loss** | **(10,462,030)** | **(2,225,250)** | - The increase in R&D and SG&A expenses for the quarter ended June 30, 2020, was primarily due to significant non-cash stock-based compensation expenses for employees, officers, and the CEO[173](index=173&type=chunk)[174](index=174&type=chunk) - Net cash provided by financing activities was **$1.8 million** for the three months ended June 30, 2020, mainly from the issuance of senior secured convertible notes and a PPP loan[184](index=184&type=chunk) - The company has incurred substantial operating losses and has an accumulated deficit of approximately **$26.9 million** at June 30, 2020, raising substantial doubt about its ability to continue as a going concern[176](index=176&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=33&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) As a Smaller Reporting Company, the company is not required to provide quantitative and qualitative disclosures regarding market risk - Disclosure is not required for a Smaller Reporting Company[190](index=190&type=chunk) [Controls and Procedures](index=33&type=section&id=Item%204.%20Controls%20and%20Procedures) Management, including the CEO, evaluated and concluded that the company's disclosure controls and procedures were effective as of June 30, 2020, with no material changes in internal control over financial reporting - Management, including the CEO, evaluated the company's disclosure controls and procedures and concluded they are effective as of the quarter ended June 30, 2020[193](index=193&type=chunk) - There were no changes in internal control over financial reporting during the fiscal quarter that have materially affected, or are reasonably likely to materially affect, internal controls[195](index=195&type=chunk) [PART II - OTHER INFORMATION](index=34&type=section&id=PART%20II%20-%20OTHER%20INFORMATION) This section provides additional information including legal proceedings, risk factors, equity sales, defaults, and exhibits [Legal Proceedings](index=34&type=section&id=Item%201.%20Legal%20Proceedings) The company is actively defending itself in a lawsuit filed by Spencer Clarke LLC concerning a 2018 Placement Agent Agreement, disputing claims and filing counterclaims - Spencer Clarke LLC filed a lawsuit against the company in August 2019 concerning a 2018 Placement Agent Agreement, alleging failure to make payments[198](index=198&type=chunk) - The company has filed an Answer and Counterclaims against Spencer Clarke, alleging breach of contract, anticipatory repudiation, and tortious interference, disputing owing any money[198](index=198&type=chunk) [Risk Factors](index=34&type=section&id=Item%201A.%20Risk%20Factors) The company identifies the COVID-19 pandemic as a significant and uncertain risk factor, potentially impacting its business, operations, and financial condition - The impact of the COVID-19 outbreak on the company's business, results of operations, and financial condition is uncertain and depends on future developments[199](index=199&type=chunk)[201](index=201&type=chunk) - The company has modified business practices, including employee travel and work locations, in response to the pandemic, but there is no certainty these measures will be sufficient[200](index=200&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=34&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) No unregistered sales of equity securities occurred during the quarter, beyond those previously disclosed in Form 8-K filings - No unregistered sales of equity securities occurred during the period, other than those previously disclosed on Form 8-K[202](index=202&type=chunk) [Defaults Upon Senior Securities](index=34&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) The company reported no defaults on senior securities during the current reporting period - None[203](index=203&type=chunk) [Mine Safety Disclosures](index=34&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This disclosure item is not applicable to the company's operations - N/A[204](index=204&type=chunk) [Other Information](index=34&type=section&id=Item%205.%20Other%20Information) No additional information is reported for this period - N/A[204](index=204&type=chunk) [Exhibits](index=34&type=section&id=Item%206.%20Exhibits) This section lists the exhibits filed with the Form 10-Q, including required certifications and XBRL data files - The report includes certifications from the Principal Executive Officer and Principal Financial Officer pursuant to Sarbanes-Oxley Act Sections 302 and 906[204](index=204&type=chunk)[205](index=205&type=chunk) - XBRL Instance Document and related taxonomy files are included as exhibits[205](index=205&type=chunk)[206](index=206&type=chunk) [Signatures](index=36&type=section&id=Signatures) This section contains the required signatures for the financial report, affirming its accuracy and completeness